{"protocolSection":{"identificationModule":{"nctId":"NCT03235050","orgStudyIdInfo":{"id":"D5670C00004"},"organization":{"fullName":"AstraZeneca","class":"INDUSTRY"},"briefTitle":"A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes","officialTitle":"A Phase IIb, Randomised, Parallel, Double-Blind Placebo-Controlled and Open-Label Active Comparator Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes Mellitus"},"statusModule":{"statusVerifiedDate":"2020-07","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2017-08-02","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2018-05-03","type":"ACTUAL"},"completionDateStruct":{"date":"2019-06-14","type":"ACTUAL"},"studyFirstSubmitDate":"2017-07-21","studyFirstSubmitQcDate":"2017-07-27","studyFirstPostDateStruct":{"date":"2017-08-01","type":"ACTUAL"},"resultsFirstSubmitDate":"2020-06-03","resultsFirstSubmitQcDate":"2020-07-03","resultsFirstPostDateStruct":{"date":"2020-07-20","type":"ACTUAL"},"dispFirstSubmitDate":"2019-03-07","dispFirstSubmitQcDate":"2020-07-03","dispFirstPostDateStruct":{"date":"2020-07-20","type":"ACTUAL"},"lastUpdateSubmitDate":"2020-07-31","lastUpdatePostDateStruct":{"date":"2020-08-17","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"AstraZeneca","class":"INDUSTRY"},"collaborators":[{"name":"MedImmune LLC","class":"INDUSTRY"}]},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":true,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This study is designed to evaluate the dose range for MEDI0382 with respect to blood glucose control and weight loss effects, as well as to further explore the safety profile of MEDI0382"},"conditionsModule":{"conditions":["Diabetes Mellitus, Type 2"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","interventionModelDescription":"Randomised, parallel, double-blind, placebo-controlled study with an open-label active comparator.","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"TRIPLE","maskingDescription":"The study will be conducted in a double-blind fashion for MEDI0382 and placebo. The sponsor staff, the subjects, and the Investigators involved in the treatment of subjects or in the clinical evaluation of subjects will not be aware of the treatment received. Liraglutide will be provided in an open-label active comparator arm.","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR"]}},"enrollmentInfo":{"count":834,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"MEDI0382 low dose + Metformin","type":"EXPERIMENTAL","description":"Drug: MEDI0382 low dose Drug: Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)","interventionNames":["Drug: MEDI0382 low dose"]},{"label":"MEDI0382 mid dose + Metformin","type":"EXPERIMENTAL","description":"Drug: MEDI0382 mid dose Drug: Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)","interventionNames":["Drug: MEDI0382 mid dose"]},{"label":"MEDI0382 high dose + Metformin","type":"EXPERIMENTAL","description":"Drug: MEDI0382 high dose Drug: Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)","interventionNames":["Drug: MEDI0382 high dose"]},{"label":"Placebo + Metformin","type":"PLACEBO_COMPARATOR","description":"Drug: Placebo Drug: Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)","interventionNames":["Drug: Placebo"]},{"label":"Liraglutide + Metformin","type":"ACTIVE_COMPARATOR","description":"Drug: Liraglutide Drug: Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)","interventionNames":["Drug: Liraglutide"]}],"interventions":[{"type":"DRUG","name":"MEDI0382 low dose","description":"Pharmaceutical form: solution Route of administration: subcutaneous","armGroupLabels":["MEDI0382 low dose + Metformin"]},{"type":"DRUG","name":"MEDI0382 mid dose","description":"Pharmaceutical form: solution Route of administration: subcutaneous","armGroupLabels":["MEDI0382 mid dose + Metformin"]},{"type":"DRUG","name":"MEDI0382 high dose","description":"Pharmaceutical form: solution Route of administration: subcutaneous","armGroupLabels":["MEDI0382 high dose + Metformin"]},{"type":"DRUG","name":"Placebo","description":"Pharmaceutical form: solution Route of administration: subcutaneous","armGroupLabels":["Placebo + Metformin"]},{"type":"DRUG","name":"Liraglutide","description":"Pharmaceutical form: solution Route of administration: subcutaneous","armGroupLabels":["Liraglutide + Metformin"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Change in HbA1c","description":"To assess the effect of 100, 200, 300 μg of cotadutide on HbA1c versus placebo","timeFrame":"From baseline to 14 weeks"},{"measure":"Percent Change in Body Weight","description":"To assess the effect of 100, 200, 300 μg of cotadutide on body weight versus placebo","timeFrame":"From baseline to 14 weeks"}],"secondaryOutcomes":[{"measure":"Change in HbA1c","description":"To assess the effect of 100, 200, 300 μg of cotadutide on HbA1c versus placebo","timeFrame":"from baseline to 26 weeks and 54 weeks"},{"measure":"Percentage of Participants Achieving an HbA1c Target < 7.0%","description":"To assess the effect of 100, 200, and 300 μg of cotadutide on percentage of participants achieving an HbA1c target of \\<7% versus placebo","timeFrame":"after 14, 26, and 54 weeks"},{"measure":"Percent Change in Body Weight","description":"To assess the effect of 100, 200, and 300 μg of cotadutide on body weight versus placebo","timeFrame":"from baseline to 26 weeks and 54 weeks"},{"measure":"Absolute Change in Body Weight","description":"To assess the effect of 100, 200, 300 μg of cotadutide on body weight versus placebo","timeFrame":"from baseline to 14 weeks, 26 weeks and 54 weeks"},{"measure":"Percent Change in Body Weight Versus Active Comparator","description":"To assess the effect of 100, 200, and 300 μg of cotadutide on body weight versus liraglutide 1.8 mg once daily","timeFrame":"from baseline to 14 weeks, 26 weeks and 54 weeks"},{"measure":"Absolute Change in Body Weight Versus Active Comparator","description":"To assess the effect of 100, 200, and 300 μg of cotadutide on body weight versus liraglutide 1.8 mg once daily","timeFrame":"from baseline to 14 weeks, 26 weeks and 54 weeks"},{"measure":"Percentage of Participants Achieving Weight Loss of ≥5% and ≥10%","description":"To assess the effect of 100, 200, and 300 μg of cotadutide on percentage of subjects achieving weight loss of ≥5% and ≥10% versus placebo","timeFrame":"after 14 weeks, 26 weeks and 54 weeks"},{"measure":"Percentage of Participants Rescued or Discontinued for Lack of Glycaemic Control","description":"To assess the effect of 100, 200, and 300 μg of cotadutide on the requirement for additional blood glucose-lowering therapies versus placebo","timeFrame":"at 14 weeks, 26 weeks and 54 weeks"},{"measure":"Pharmacokinetic (PK) Endpoint: Trough Plasma Concentration (Cmin)","description":"To characterise the PK profile of 100, 200, and 300 μg of cotadutide","timeFrame":"Time points at which outcome measure were assessed for plasma concentration were Weeks 1,2,6,10,14,18,22,26, and 54"},{"measure":"Immunogenicity Endpoint: Overall Antidrug Antibody (ADA) Incidence (Number and Percentage of Positive Partipants)","description":"To characterise the immunogenicity of 100, 200, and 300 μg of cotadutide","timeFrame":"Baseline through 54-week treatment period and 28-day follow-up"},{"measure":"Immunogenicity Endpoint: Median Titer of the Anti-Drug Antibodies (ADA) to MEDI0382 in the Positive Participants","description":"To characterise the immunogenicity of 100, 200, and 300 μg of cotadutide","timeFrame":"Baseline through 54-week treatment period and 28-day follow-up"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Provision of informed consent\n* Male and female subjects aged ≥ 18 years at screening\n* Body mass index ≥ 25 kg/m2 at screening\n* HbA1c range of 7.0% to 10.5% (inclusive) at screening\n* Diagnosed with type-2 diabetes mellitus (T2DM) and treated with metformin (stable dose of ≥1500 mg/day or maximal tolerated dose) for at least 2 months prior to screening. Use of another glucose-lowering medication for up to 2 weeks in the 2 months prior to screening is acceptable\n* Women of childbearing potential (WOCBP), not breastfeeding and using appropriate birth control to avoid pregnancy throughout the study and for up to 4 weeks after the last dose of investigational product (IP), with a negative pregnancy test within 72 hours prior to the start of IP\n\nExclusion Criteria:\n\n* History of, or any existing condition that, in the opinion of the Investigator, would interfere with evaluation of the IP, put the subject at risk, influence the subject's ability to participate or affect the interpretation of the results of the study and/or any subject unable or unwilling to follow study procedures\n* Any subject who has received another IP as part of a clinical study or a GLP-1 receptor agonist containing preparation within the last 30 days or 5 half lives of the drug (whichever is longer) at the time of screening\n* Severe allergy/hypersensitivity to any of the proposed study treatments or excipients\n* Symptoms of acutely decompensated blood glucose control, a history of type 1 diabetes mellitus or diabetic ketoacidosis, or if the subject has been treated with daily subcutaneous (SC) insulin for a period longer than 2 weeks within 90 days prior to screening\n* Acute or chronic pancreatitis. Subjects with serum triglyceride concentrations above 1000 mg/dL (11 mmol/L) at screening\n* Significant inflammatory bowel disease or other severe disease or surgery affecting the upper Gastrointestinal (GI) tract\n* Significant hepatic disease\n* Impaired renal function defined as estimated glomerular filtration rate (eGFR) ≤30 mL/minute/1.73m2 at screening\n* Severely uncontrolled hypertension\n* Unstable angina pectoris, myocardial infarction (MI), transient ischaemic attack (TIA), or stroke within 3 months prior to screening\n* Severe congestive heart failure","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","maximumAge":"130 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"locations":[{"facility":"Research Site","city":"Birmingham","state":"Alabama","zip":"35205","country":"United States","geoPoint":{"lat":33.52066,"lon":-86.80249}},{"facility":"Research Site","city":"Chandler","state":"Arizona","zip":"85224","country":"United States","geoPoint":{"lat":33.30616,"lon":-111.84125}},{"facility":"Research Site","city":"Glendale","state":"Arizona","zip":"85306","country":"United States","geoPoint":{"lat":33.53865,"lon":-112.18599}},{"facility":"Research Site","city":"Glendale","state":"Arizona","zip":"85308","country":"United States","geoPoint":{"lat":33.53865,"lon":-112.18599}},{"facility":"Research Site","city":"Mesa","state":"Arizona","zip":"85213","country":"United States","geoPoint":{"lat":33.42227,"lon":-111.82264}},{"facility":"Research Site","city":"Marietta","state":"Georgia","zip":"30067","country":"United States","geoPoint":{"lat":33.9526,"lon":-84.54993}},{"facility":"Research Site","city":"Evansville","state":"Indiana","zip":"47715","country":"United States","geoPoint":{"lat":37.97476,"lon":-87.55585}},{"facility":"Research Site","city":"Baton Rouge","state":"Louisiana","zip":"70808","country":"United States","geoPoint":{"lat":30.44332,"lon":-91.18747}},{"facility":"Research Site","city":"Metairie","state":"Louisiana","zip":"70006","country":"United States","geoPoint":{"lat":29.98409,"lon":-90.15285}},{"facility":"Research Site","city":"Elkridge","state":"Maryland","zip":"21075","country":"United States","geoPoint":{"lat":39.21261,"lon":-76.71358}},{"facility":"Research Site","city":"Bridgeton","state":"Missouri","zip":"63044","country":"United States","geoPoint":{"lat":38.767,"lon":-90.41151}},{"facility":"Research Site","city":"Las Vegas","state":"Nevada","zip":"89117","country":"United States","geoPoint":{"lat":36.17497,"lon":-115.13722}},{"facility":"Research Site","city":"Brooklyn","state":"New York","zip":"11229","country":"United States","geoPoint":{"lat":40.6501,"lon":-73.94958}},{"facility":"Research Site","city":"Morehead City","state":"North Carolina","zip":"28557","country":"United States","geoPoint":{"lat":34.72294,"lon":-76.72604}},{"facility":"Research Site","city":"Philadelphia","state":"Pennsylvania","zip":"19104","country":"United States","geoPoint":{"lat":39.95238,"lon":-75.16362}},{"facility":"Research Site","city":"Greer","state":"South Carolina","zip":"29651","country":"United States","geoPoint":{"lat":34.93873,"lon":-82.22706}},{"facility":"Research Site","city":"Houston","state":"Texas","zip":"77040","country":"United States","geoPoint":{"lat":29.76328,"lon":-95.36327}},{"facility":"Research Site","city":"Houston","state":"Texas","zip":"77074","country":"United States","geoPoint":{"lat":29.76328,"lon":-95.36327}},{"facility":"Research Site","city":"Plano","state":"Texas","zip":"75093","country":"United States","geoPoint":{"lat":33.01984,"lon":-96.69889}},{"facility":"Research Site","city":"Layton","state":"Utah","zip":"84014","country":"United States","geoPoint":{"lat":41.06022,"lon":-111.97105}},{"facility":"Research Site","city":"Arlington","state":"Virginia","zip":"22206","country":"United States","geoPoint":{"lat":38.88101,"lon":-77.10428}},{"facility":"Research Site","city":"Manassas","state":"Virginia","zip":"20110","country":"United States","geoPoint":{"lat":38.75095,"lon":-77.47527}},{"facility":"Research Site","city":"Botevgrad","zip":"2140","country":"Bulgaria","geoPoint":{"lat":42.90799,"lon":23.79274}},{"facility":"Research Site","city":"Kozloduy","country":"Bulgaria","geoPoint":{"lat":43.77691,"lon":23.73001}},{"facility":"Research Site","city":"Kyustendil","zip":"2500","country":"Bulgaria","geoPoint":{"lat":42.28314,"lon":22.69224}},{"facility":"Research Site","city":"Lukovit","country":"Bulgaria","geoPoint":{"lat":43.2,"lon":24.16667}},{"facility":"Research Site","city":"Petrich","zip":"2850","country":"Bulgaria","geoPoint":{"lat":41.39365,"lon":23.20012}},{"facility":"Research Site","city":"Pleven","zip":"5800","country":"Bulgaria","geoPoint":{"lat":43.41791,"lon":24.61666}},{"facility":"Research Site","city":"Plovdiv","zip":"4000","country":"Bulgaria","geoPoint":{"lat":42.15387,"lon":24.75001}},{"facility":"Research Site","city":"Rousse","zip":"7002","country":"Bulgaria","geoPoint":{"lat":43.84872,"lon":25.9534}},{"facility":"Research Site","city":"Sofia","zip":"1223","country":"Bulgaria","geoPoint":{"lat":42.69751,"lon":23.32415}},{"facility":"Research Site","city":"Sofia","zip":"1407","country":"Bulgaria","geoPoint":{"lat":42.69751,"lon":23.32415}},{"facility":"Research Site","city":"Sofia","zip":"1606","country":"Bulgaria","geoPoint":{"lat":42.69751,"lon":23.32415}},{"facility":"Research Site","city":"Sofia","zip":"1618","country":"Bulgaria","geoPoint":{"lat":42.69751,"lon":23.32415}},{"facility":"Research Site","city":"Stara Zagora","zip":"6000","country":"Bulgaria","geoPoint":{"lat":42.43205,"lon":25.64262}},{"facility":"Research Site","city":"Red Deer","state":"Alberta","zip":"T4N 6V7","country":"Canada","geoPoint":{"lat":52.26682,"lon":-113.802}},{"facility":"Research Site","city":"Sherwood Park","state":"Alberta","zip":"T8L 0N2","country":"Canada","geoPoint":{"lat":53.51684,"lon":-113.3187}},{"facility":"Research Site","city":"Burlington","state":"Ontario","zip":"L7M 4Y1","country":"Canada","geoPoint":{"lat":43.38621,"lon":-79.83713}},{"facility":"Research Site","city":"Etobicoke","state":"Ontario","zip":"M9W 4L6","country":"Canada","geoPoint":{"lat":43.64415,"lon":-79.56985}},{"facility":"Research Site","city":"Guelph","state":"Ontario","zip":"N1H 1B1","country":"Canada","geoPoint":{"lat":43.54594,"lon":-80.25599}},{"facility":"Research Site","city":"London","state":"Ontario","zip":"N5W 6A2","country":"Canada","geoPoint":{"lat":42.98339,"lon":-81.23304}},{"facility":"Research Site","city":"London","state":"Ontario","zip":"N6G 5A9","country":"Canada","geoPoint":{"lat":42.98339,"lon":-81.23304}},{"facility":"Research Site","city":"Newmarket","state":"Ontario","zip":"L3Y 5G8","country":"Canada","geoPoint":{"lat":44.05011,"lon":-79.46631}},{"facility":"Research Site","city":"Sarnia","state":"Ontario","zip":"N7T 4X3","country":"Canada","geoPoint":{"lat":42.97866,"lon":-82.40407}},{"facility":"Research Site","city":"Thornhill","state":"Ontario","zip":"L4J 8L7","country":"Canada","geoPoint":{"lat":43.815,"lon":-79.4242}},{"facility":"Research Site","city":"Toronto","state":"Ontario","zip":"M4G 3E8","country":"Canada","geoPoint":{"lat":43.70643,"lon":-79.39864}},{"facility":"Research Site","city":"Lévis","state":"Quebec","zip":"G6W 0M5","country":"Canada","geoPoint":{"lat":46.80326,"lon":-71.17793}},{"facility":"Research Site","city":"Montreal","state":"Quebec","zip":"H4A 3T2","country":"Canada","geoPoint":{"lat":45.50884,"lon":-73.58781}},{"facility":"Research Site","city":"Montreal","state":"Quebec","zip":"H4N 2W2","country":"Canada","geoPoint":{"lat":45.50884,"lon":-73.58781}},{"facility":"Research Site","city":"Saint-Marc-des-Carrieres","state":"Quebec","zip":"G0A 4B0","country":"Canada","geoPoint":{"lat":46.68335,"lon":-72.0491}},{"facility":"Research Site","city":"Beroun","zip":"266 00","country":"Czechia","geoPoint":{"lat":49.96382,"lon":14.072}},{"facility":"Research Site","city":"Jílové u Prahy","zip":"254 01","country":"Czechia","geoPoint":{"lat":49.89545,"lon":14.49333}},{"facility":"Research Site","city":"Pardubice","zip":"530 02","country":"Czechia","geoPoint":{"lat":50.04075,"lon":15.77659}},{"facility":"Research Site","city":"Pilsen","zip":"301 66","country":"Czechia","geoPoint":{"lat":49.74747,"lon":13.37759}},{"facility":"Research Site","city":"Plzen - Severni Predmesti","zip":"301 00","country":"Czechia"},{"facility":"Research Site","city":"Prague","zip":"104 00","country":"Czechia","geoPoint":{"lat":50.08804,"lon":14.42076}},{"facility":"Research Site","city":"Prague","zip":"140 00","country":"Czechia","geoPoint":{"lat":50.08804,"lon":14.42076}},{"facility":"Research Site","city":"Prague","zip":"140 59","country":"Czechia","geoPoint":{"lat":50.08804,"lon":14.42076}},{"facility":"Research Site","city":"Prague","zip":"149 00","country":"Czechia","geoPoint":{"lat":50.08804,"lon":14.42076}},{"facility":"Research Site","city":"Praha Klanovice","zip":"190 14","country":"Czechia","geoPoint":{"lat":50.0974,"lon":14.66915}},{"facility":"Research Site","city":"Uherské Hradiště","zip":"686 01","country":"Czechia","geoPoint":{"lat":49.06975,"lon":17.45969}},{"facility":"Research Site","city":"Aschaffenburg","zip":"63739","country":"Germany","geoPoint":{"lat":49.97704,"lon":9.15214}},{"facility":"Research Site","city":"Berlin","zip":"10437","country":"Germany","geoPoint":{"lat":52.52437,"lon":13.41053}},{"facility":"Research Site","city":"Berlin","zip":"10787","country":"Germany","geoPoint":{"lat":52.52437,"lon":13.41053}},{"facility":"Research Site","city":"Eschweiler","zip":"52249","country":"Germany","geoPoint":{"lat":50.81854,"lon":6.27184}},{"facility":"Research Site","city":"Essen","zip":"45136","country":"Germany","geoPoint":{"lat":51.45657,"lon":7.01228}},{"facility":"Research Site","city":"Essen","zip":"45359","country":"Germany","geoPoint":{"lat":51.45657,"lon":7.01228}},{"facility":"Research Site","city":"Gelnhausen","zip":"63571","country":"Germany","geoPoint":{"lat":50.20164,"lon":9.18742}},{"facility":"Research Site","city":"Hamburg","zip":"21109","country":"Germany","geoPoint":{"lat":53.55073,"lon":9.99302}},{"facility":"Research Site","city":"Hamburg","zip":"22607","country":"Germany","geoPoint":{"lat":53.55073,"lon":9.99302}},{"facility":"Research Site","city":"Hof","zip":"95030","country":"Germany","geoPoint":{"lat":50.31297,"lon":11.91261}},{"facility":"Research Site","city":"Löhne","zip":"32584","country":"Germany","geoPoint":{"lat":52.18848,"lon":8.6922}},{"facility":"Research Site","city":"Lübeck","zip":"23538","country":"Germany","geoPoint":{"lat":53.86893,"lon":10.68729}},{"facility":"Research Site","city":"Magdeburg","zip":"39120","country":"Germany","geoPoint":{"lat":52.13129,"lon":11.63189}},{"facility":"Research Site","city":"Mannheim","zip":"68163","country":"Germany","geoPoint":{"lat":49.4891,"lon":8.46694}},{"facility":"Research Site","city":"Münster","zip":"48145","country":"Germany","geoPoint":{"lat":51.96236,"lon":7.62571}},{"facility":"Research Site","city":"Oldenburg","zip":"23758","country":"Germany","geoPoint":{"lat":53.14039,"lon":8.21479}},{"facility":"Research Site","city":"Pirna","zip":"01796","country":"Germany","geoPoint":{"lat":50.95843,"lon":13.93702}},{"facility":"Research Site","city":"Rhaunen","zip":"55624","country":"Germany","geoPoint":{"lat":49.8638,"lon":7.34198}},{"facility":"Research Site","city":"Villingen-Schwenningen","zip":"78048","country":"Germany","geoPoint":{"lat":48.06226,"lon":8.49358}},{"facility":"Research Site","city":"Guadalajara","zip":"44670","country":"Mexico","geoPoint":{"lat":20.67738,"lon":-103.34749}},{"facility":"Research Site","city":"México","zip":"03300","country":"Mexico","geoPoint":{"lat":25.80426,"lon":-109.02397}},{"facility":"Research Site","city":"México","zip":"11650","country":"Mexico","geoPoint":{"lat":25.80426,"lon":-109.02397}},{"facility":"Research Site","city":"Monterrey","zip":"66465","country":"Mexico","geoPoint":{"lat":25.68435,"lon":-100.31721}},{"facility":"Research Site","city":"Veracruz","zip":"91900","country":"Mexico","geoPoint":{"lat":19.18095,"lon":-96.1429}},{"facility":"Research Site","city":"Veracruz","zip":"91910","country":"Mexico","geoPoint":{"lat":19.18095,"lon":-96.1429}},{"facility":"Research Site","city":"Chelyabinsk","zip":"454091","country":"Russia","geoPoint":{"lat":55.1611,"lon":61.42877}},{"facility":"Research Site","city":"Izhevsk","zip":"426035","country":"Russia","geoPoint":{"lat":56.85225,"lon":53.19862}},{"facility":"Research Site","city":"Kemerovo","zip":"650066","country":"Russia","geoPoint":{"lat":55.35417,"lon":86.10435}},{"facility":"Research Site","city":"Moscow","zip":"119034","country":"Russia","geoPoint":{"lat":55.75204,"lon":37.61781}},{"facility":"Research Site","city":"Moscow","zip":"119435","country":"Russia","geoPoint":{"lat":55.75204,"lon":37.61781}},{"facility":"Research Site","city":"Moscow","zip":"125367","country":"Russia","geoPoint":{"lat":55.75204,"lon":37.61781}},{"facility":"Research Site","city":"Novosibirsk","zip":"630051","country":"Russia","geoPoint":{"lat":55.02259,"lon":82.93175}},{"facility":"Research Site","city":"Perm","zip":"614000","country":"Russia","geoPoint":{"lat":58.01046,"lon":56.25017}},{"facility":"Research Site","city":"Perm","zip":"614068","country":"Russia","geoPoint":{"lat":58.01046,"lon":56.25017}},{"facility":"Research Site","city":"Saint Petersburg","zip":"196084","country":"Russia","geoPoint":{"lat":59.93863,"lon":30.31413}},{"facility":"Research Site","city":"Saint Petersburg","zip":"196601","country":"Russia","geoPoint":{"lat":59.93863,"lon":30.31413}},{"facility":"Research Site","city":"Saint Petersburg","zip":"198013","country":"Russia","geoPoint":{"lat":59.93863,"lon":30.31413}},{"facility":"Research Site","city":"Saint Petersburg","zip":"199226","country":"Russia","geoPoint":{"lat":59.93863,"lon":30.31413}},{"facility":"Research Site","city":"Vladikavkaz","zip":"362007","country":"Russia","geoPoint":{"lat":43.04101,"lon":44.66986}},{"facility":"Research Site","city":"Volgograd","zip":"400131","country":"Russia","geoPoint":{"lat":48.71378,"lon":44.4976}},{"facility":"Research Site","city":"Yekaterinburg","zip":"620039","country":"Russia","geoPoint":{"lat":56.85733,"lon":60.61529}},{"facility":"Research Site","city":"Banská Bystrica","zip":"974 01","country":"Slovakia","geoPoint":{"lat":48.73947,"lon":19.14932}},{"facility":"Research Site","city":"Bratislava","zip":"831 01","country":"Slovakia","geoPoint":{"lat":48.14816,"lon":17.10674}},{"facility":"Research Site","city":"Dolný Kubín","zip":"026 01","country":"Slovakia","geoPoint":{"lat":49.20983,"lon":19.30341}},{"facility":"Research Site","city":"Levice","zip":"934 01","country":"Slovakia","geoPoint":{"lat":48.21563,"lon":18.60705}},{"facility":"Research Site","city":"Lučenec","zip":"984 01","country":"Slovakia","geoPoint":{"lat":48.33249,"lon":19.66708}},{"facility":"Research Site","city":"Malacky","zip":"901 01","country":"Slovakia","geoPoint":{"lat":48.43604,"lon":17.02188}},{"facility":"Research Site","city":"Námestovo","zip":"029 01","country":"Slovakia","geoPoint":{"lat":49.4079,"lon":19.48032}},{"facility":"Research Site","city":"Nitra","zip":"949 11","country":"Slovakia","geoPoint":{"lat":48.30763,"lon":18.08453}},{"facility":"Research Site","city":"Nové Mesto nad Váhom","zip":"915 01","country":"Slovakia","geoPoint":{"lat":48.75763,"lon":17.8309}},{"facility":"Research Site","city":"Prievidza","zip":"971 01","country":"Slovakia","geoPoint":{"lat":48.77446,"lon":18.6275}},{"facility":"Research Site","city":"Rimavská Sobota","zip":"979 01","country":"Slovakia","geoPoint":{"lat":48.38284,"lon":20.02239}},{"facility":"Research Site","city":"Rožňava","zip":"048 01","country":"Slovakia","geoPoint":{"lat":48.66009,"lon":20.53758}},{"facility":"Research Site","city":"Sabinov","zip":"083 01","country":"Slovakia","geoPoint":{"lat":49.10309,"lon":21.0988}},{"facility":"Research Site","city":"Trebišov","zip":"075 01","country":"Slovakia","geoPoint":{"lat":48.62858,"lon":21.71954}},{"facility":"Research Site","city":"Trenčín","zip":"911 01","country":"Slovakia","geoPoint":{"lat":48.89452,"lon":18.04436}},{"facility":"Research Site","city":"Trnava","zip":"917 01","country":"Slovakia","geoPoint":{"lat":48.37773,"lon":17.58603}},{"facility":"Research Site","city":"Žilina","zip":"010 01","country":"Slovakia","geoPoint":{"lat":49.22315,"lon":18.73941}}]},"referencesModule":{"references":[{"pmid":"34016612","type":"DERIVED","citation":"Nahra R, Wang T, Gadde KM, Oscarsson J, Stumvoll M, Jermutus L, Hirshberg B, Ambery P. Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study. Diabetes Care. 2021 Jun;44(6):1433-1442. doi: 10.2337/dc20-2151. Epub 2021 May 20."}],"seeAlsoLinks":[{"label":"D5670C00004 SAP redacted","url":"https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D5670C00004&amp;attachmentIdentifier=d3772b2d-e5a9-4fef-b796-e371735f6b2d&amp;fileName=D5670C00004_SAP_redacted.pdf&amp;versionIdentifier="},{"label":"D5670C00004 CSP redacted","url":"https://filehosting-v2.pharmacm.com/api/Attachment/Download?tenantId=80217111&amp;parentIdentifier=D5670C00004&amp;attachmentIdentifier=e91d84a4-416d-4262-aea8-98b99f6854c5&amp;fileName=D5670C00004_CSP_redacted.pdf&amp;versionIdentifier="}]}},"resultsSection":{"participantFlowModule":{"groups":[{"id":"FG000","title":"Placebo","description":"Placebo / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"FG001","title":"Liraglutide","description":"Liraglutide + Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"FG002","title":"MEDI0382 100 mcg","description":"MEDI0382(cotadutide) low dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"FG003","title":"MEDI0382 200 mcg","description":"MEDI0382(cotadutide) mid dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"FG004","title":"MEDI0382 300 mcg","description":"MEDI0382(cotadutide) high dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"112"},{"groupId":"FG001","numSubjects":"110"},{"groupId":"FG002","numSubjects":"100"},{"groupId":"FG003","numSubjects":"256"},{"groupId":"FG004","numSubjects":"256"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"108"},{"groupId":"FG001","numSubjects":"105"},{"groupId":"FG002","numSubjects":"96"},{"groupId":"FG003","numSubjects":"242"},{"groupId":"FG004","numSubjects":"245"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"4"},{"groupId":"FG001","numSubjects":"5"},{"groupId":"FG002","numSubjects":"4"},{"groupId":"FG003","numSubjects":"14"},{"groupId":"FG004","numSubjects":"11"}]}],"dropWithdraws":[{"type":"Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"4"},{"groupId":"FG004","numSubjects":"1"}]},{"type":"Death","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"2"},{"groupId":"FG004","numSubjects":"1"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"2"},{"groupId":"FG004","numSubjects":"0"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"3"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"2"},{"groupId":"FG003","numSubjects":"5"},{"groupId":"FG004","numSubjects":"7"}]},{"type":"Other reasons","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"1"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"2"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Placebo","description":"Placebo / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"BG001","title":"Liraglutide","description":"Liraglutide + Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"BG002","title":"MEDI0382 100 mcg","description":"MEDI0382 low dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"BG003","title":"MEDI0382 200 mcg","description":"MEDI0382 mid dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"BG004","title":"MEDI0382 300 mcg","description":"MEDI0382 high dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"BG005","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"112"},{"groupId":"BG001","value":"110"},{"groupId":"BG002","value":"100"},{"groupId":"BG003","value":"256"},{"groupId":"BG004","value":"256"},{"groupId":"BG005","value":"834"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"Years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"57.3","spread":"9.5"},{"groupId":"BG001","value":"55.5","spread":"9.8"},{"groupId":"BG002","value":"57.6","spread":"9.9"},{"groupId":"BG003","value":"57.3","spread":"9.9"},{"groupId":"BG004","value":"56.3","spread":"10.2"},{"groupId":"BG005","value":"56.8","spread":"9.9"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"55"},{"groupId":"BG001","value":"60"},{"groupId":"BG002","value":"57"},{"groupId":"BG003","value":"147"},{"groupId":"BG004","value":"129"},{"groupId":"BG005","value":"448"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"57"},{"groupId":"BG001","value":"50"},{"groupId":"BG002","value":"43"},{"groupId":"BG003","value":"109"},{"groupId":"BG004","value":"127"},{"groupId":"BG005","value":"386"}]}]}]},{"title":"Race/Ethnicity, Customized","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"American Indian or Alaska Native","measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"5"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"11"}]},{"title":"Asian","measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"3"},{"groupId":"BG004","value":"1"},{"groupId":"BG005","value":"6"}]},{"title":"Black or African American","measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"3"},{"groupId":"BG004","value":"3"},{"groupId":"BG005","value":"10"}]},{"title":"White","measurements":[{"groupId":"BG000","value":"107"},{"groupId":"BG001","value":"103"},{"groupId":"BG002","value":"99"},{"groupId":"BG003","value":"245"},{"groupId":"BG004","value":"252"},{"groupId":"BG005","value":"806"}]},{"title":"Other","measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"1"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Change in HbA1c","description":"To assess the effect of 100, 200, 300 μg of cotadutide on HbA1c versus placebo","populationDescription":"ITT population","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"percentage","timeFrame":"From baseline to 14 weeks","groups":[{"id":"OG000","title":"Placebo","description":"Placebo / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG001","title":"MEDI0382 100 mcg","description":"MEDI0382 low dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG002","title":"MEDI0382 200 mcg","description":"MEDI0382 mid dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG003","title":"MEDI0382 300 mcg","description":"MEDI0382 high dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"100"},{"groupId":"OG002","value":"256"},{"groupId":"OG003","value":"256"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.18","lowerLimit":"-0.34","upperLimit":"-0.02"},{"groupId":"OG001","value":"-1.01","lowerLimit":"-1.18","upperLimit":"-0.84"},{"groupId":"OG002","value":"-1.22","lowerLimit":"-1.33","upperLimit":"-1.11"},{"groupId":"OG003","value":"-1.09","lowerLimit":"-1.20","upperLimit":"-0.98"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-0.83","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-1.06","ciUpperLimit":"-0.59"},{"groupIds":["OG000","OG002"],"nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-1.04","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-1.23","ciUpperLimit":"-0.85"},{"groupIds":["OG000","OG003"],"nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-0.91","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-1.11","ciUpperLimit":"-0.72"}]},{"type":"PRIMARY","title":"Percent Change in Body Weight","description":"To assess the effect of 100, 200, 300 μg of cotadutide on body weight versus placebo","populationDescription":"ITT population","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"percentage","timeFrame":"From baseline to 14 weeks","groups":[{"id":"OG000","title":"Placebo","description":"Placebo / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG001","title":"MEDI0382 100 mcg","description":"MEDI0382 low dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG002","title":"MEDI0382 200 mcg","description":"MEDI0382 mid dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG003","title":"MEDI0382 300 mcg","description":"MEDI0382 high dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"100"},{"groupId":"OG002","value":"256"},{"groupId":"OG003","value":"256"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-0.70","lowerLimit":"-1.44","upperLimit":"0.04"},{"groupId":"OG001","value":"-2.70","lowerLimit":"-3.49","upperLimit":"-1.91"},{"groupId":"OG002","value":"-3.47","lowerLimit":"-3.95","upperLimit":"-2.98"},{"groupId":"OG003","value":"-4.33","lowerLimit":"-4.82","upperLimit":"-3.84"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-2.00","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-3.08","ciUpperLimit":"-0.91"},{"groupIds":["OG000","OG002"],"nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-2.76","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-3.65","ciUpperLimit":"-1.87"},{"groupIds":["OG000","OG003"],"nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-3.62","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-4.51","ciUpperLimit":"-2.73"}]},{"type":"SECONDARY","title":"Change in HbA1c","description":"To assess the effect of 100, 200, 300 μg of cotadutide on HbA1c versus placebo","populationDescription":"ITT population","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"percentage","timeFrame":"from baseline to 26 weeks and 54 weeks","groups":[{"id":"OG000","title":"Placebo","description":"Placebo / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG001","title":"MEDI0382 100 mcg","description":"MEDI0382 low dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG002","title":"MEDI0382 200 mcg","description":"MEDI0382 mid dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG003","title":"MEDI0382 300 mcg","description":"MEDI0382 high dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"100"},{"groupId":"OG002","value":"256"},{"groupId":"OG003","value":"256"}]}],"classes":[{"title":"from baseline to 26 weeks","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"98"},{"groupId":"OG002","value":"252"},{"groupId":"OG003","value":"252"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-0.40","lowerLimit":"-0.58","upperLimit":"-0.22"},{"groupId":"OG001","value":"-1.06","lowerLimit":"-1.25","upperLimit":"-0.87"},{"groupId":"OG002","value":"-1.22","lowerLimit":"-1.34","upperLimit":"-1.10"},{"groupId":"OG003","value":"-1.12","lowerLimit":"-1.24","upperLimit":"-1.00"}]}]},{"title":"from baseline to 54 weeks","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"98"},{"groupId":"OG002","value":"252"},{"groupId":"OG003","value":"252"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-0.44","lowerLimit":"-0.63","upperLimit":"-0.24"},{"groupId":"OG001","value":"-0.96","lowerLimit":"-1.16","upperLimit":"-0.75"},{"groupId":"OG002","value":"-1.06","lowerLimit":"-1.19","upperLimit":"-0.93"},{"groupId":"OG003","value":"-1.01","lowerLimit":"-1.14","upperLimit":"-0.88"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"groupDescription":"Week 26","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-0.66","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-0.92","ciUpperLimit":"-0.40"},{"groupIds":["OG000","OG002"],"groupDescription":"Week 26","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-0.81","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-1.03","ciUpperLimit":"-0.60"},{"groupIds":["OG000","OG003"],"groupDescription":"Week 26","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-0.72","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-0.94","ciUpperLimit":"-0.51"},{"groupIds":["OG000","OG001"],"groupDescription":"Week 54","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-0.52","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-0.80","ciUpperLimit":"-0.24"},{"groupIds":["OG000","OG002"],"groupDescription":"Week 54","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-0.63","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-0.86","ciUpperLimit":"-0.39"},{"groupIds":["OG000","OG003"],"groupDescription":"Week 54","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-0.57","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-0.80","ciUpperLimit":"-0.34"}]},{"type":"SECONDARY","title":"Percentage of Participants Achieving an HbA1c Target < 7.0%","description":"To assess the effect of 100, 200, and 300 μg of cotadutide on percentage of participants achieving an HbA1c target of \\<7% versus placebo","populationDescription":"Intent-to-Treat (ITT) population","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"after 14, 26, and 54 weeks","groups":[{"id":"OG000","title":"Placebo","description":"Placebo / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG001","title":"MEDI0382 100 mcg","description":"MEDI0382 low dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG002","title":"MEDI0382 200 mcg","description":"MEDI0382 mid dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG003","title":"MEDI0382 300 mcg","description":"MEDI0382 high dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"100"},{"groupId":"OG002","value":"256"},{"groupId":"OG003","value":"256"}]}],"classes":[{"title":"after 14 weeks","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"98"},{"groupId":"OG002","value":"252"},{"groupId":"OG003","value":"252"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"19"},{"groupId":"OG001","value":"50"},{"groupId":"OG002","value":"143"},{"groupId":"OG003","value":"143"}]}]},{"title":"after 26 weeks","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"98"},{"groupId":"OG002","value":"252"},{"groupId":"OG003","value":"252"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"25"},{"groupId":"OG001","value":"48"},{"groupId":"OG002","value":"139"},{"groupId":"OG003","value":"143"}]}]},{"title":"after 54 weeks","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"98"},{"groupId":"OG002","value":"252"},{"groupId":"OG003","value":"252"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"23"},{"groupId":"OG001","value":"52"},{"groupId":"OG002","value":"125"},{"groupId":"OG003","value":"128"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"groupDescription":"Week 14","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"6.67","ciPctValue":"92","ciNumSides":"TWO_SIDED","ciLowerLimit":"3.34","ciUpperLimit":"13.30"},{"groupIds":["OG000","OG002"],"groupDescription":"Week 14","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"9.95","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"5.39","ciUpperLimit":"18.36"},{"groupIds":["OG000","OG003"],"groupDescription":"Week 14","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"8.52","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"4.65","ciUpperLimit":"15.61"},{"groupIds":["OG000","OG001"],"groupDescription":"Week 26","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"3.74","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"1.98","ciUpperLimit":"7.03"},{"groupIds":["OG000","OG002"],"groupDescription":"Week 26","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"5.40","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"3.13","ciUpperLimit":"9.34"},{"groupIds":["OG000","OG003"],"groupDescription":"Week 26","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"5.20","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"3.02","ciUpperLimit":"8.97"},{"groupIds":["OG000","OG001"],"groupDescription":"Week 54","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"4.94","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"2.61","ciUpperLimit":"9.36"},{"groupIds":["OG000","OG002"],"groupDescription":"Week 54","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"4.55","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"2.62","ciUpperLimit":"7.89"},{"groupIds":["OG000","OG003"],"groupDescription":"Week 54","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"4.34","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"2.51","ciUpperLimit":"7.51"}]},{"type":"SECONDARY","title":"Percent Change in Body Weight","description":"To assess the effect of 100, 200, and 300 μg of cotadutide on body weight versus placebo","populationDescription":"ITT population","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"percentage","timeFrame":"from baseline to 26 weeks and 54 weeks","groups":[{"id":"OG000","title":"Placebo","description":"Placebo / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG001","title":"MEDI0382 100 mcg","description":"MEDI0382 low dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG002","title":"MEDI0382 200 mcg","description":"MEDI0382 mid dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG003","title":"MEDI0382 300 mcg","description":"MEDI0382 high dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"100"},{"groupId":"OG002","value":"256"},{"groupId":"OG003","value":"256"}]}],"classes":[{"title":"from baseline to 26 weeks","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"98"},{"groupId":"OG002","value":"253"},{"groupId":"OG003","value":"250"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-1.14","lowerLimit":"-1.99","upperLimit":"-0.29"},{"groupId":"OG001","value":"-3.23","lowerLimit":"-4.13","upperLimit":"-2.32"},{"groupId":"OG002","value":"-3.94","lowerLimit":"-4.51","upperLimit":"-3.38"},{"groupId":"OG003","value":"-4.60","lowerLimit":"-5.17","upperLimit":"-4.04"}]}]},{"title":"from baseline to 54 weeks","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"98"},{"groupId":"OG002","value":"253"},{"groupId":"OG003","value":"250"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-0.84","lowerLimit":"-1.82","upperLimit":"0.14"},{"groupId":"OG001","value":"-3.27","lowerLimit":"-4.32","upperLimit":"-2.22"},{"groupId":"OG002","value":"-3.08","lowerLimit":"-3.73","upperLimit":"-2.43"},{"groupId":"OG003","value":"-4.16","lowerLimit":"-4.81","upperLimit":"-3.50"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"groupDescription":"Week 26","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-2.09","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-3.32","ciUpperLimit":"-0.85"},{"groupIds":["OG000","OG002"],"groupDescription":"Week 26","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-2.80","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-3.82","ciUpperLimit":"-1.79"},{"groupIds":["OG000","OG003"],"groupDescription":"Week 26","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-3.46","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-4.48","ciUpperLimit":"-2.44"},{"groupIds":["OG000","OG001"],"groupDescription":"Week 54","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-2.43","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-3.86","ciUpperLimit":"-1.00"},{"groupIds":["OG000","OG002"],"groupDescription":"Week 54","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-2.24","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-3.41","ciUpperLimit":"-1.06"},{"groupIds":["OG000","OG003"],"groupDescription":"Week 54","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-3.32","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-4.49","ciUpperLimit":"-2.14"}]},{"type":"SECONDARY","title":"Absolute Change in Body Weight","description":"To assess the effect of 100, 200, 300 μg of cotadutide on body weight versus placebo","populationDescription":"ITT population","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"kg","timeFrame":"from baseline to 14 weeks, 26 weeks and 54 weeks","groups":[{"id":"OG000","title":"Placebo","description":"Placebo / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG001","title":"MEDI0382 100 mcg","description":"MEDI0382 low dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG002","title":"MEDI0382 200 mcg","description":"MEDI0382 mid dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG003","title":"MEDI0382 300 mcg","description":"MEDI0382 high dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"100"},{"groupId":"OG002","value":"256"},{"groupId":"OG003","value":"256"}]}],"classes":[{"title":"from baseline to 14 weeks","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"108"},{"groupId":"OG001","value":"94"},{"groupId":"OG002","value":"248"},{"groupId":"OG003","value":"245"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-0.71","lowerLimit":"-1.44","upperLimit":"0.03"},{"groupId":"OG001","value":"-2.66","lowerLimit":"-3.45","upperLimit":"-1.87"},{"groupId":"OG002","value":"-3.45","lowerLimit":"-3.94","upperLimit":"-2.97"},{"groupId":"OG003","value":"-4.42","lowerLimit":"-4.91","upperLimit":"-3.93"}]}]},{"title":"from baseline to 26 weeks","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"98"},{"groupId":"OG002","value":"253"},{"groupId":"OG003","value":"250"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-1.20","lowerLimit":"-2.06","upperLimit":"-0.34"},{"groupId":"OG001","value":"-3.20","lowerLimit":"-4.13","upperLimit":"-2.28"},{"groupId":"OG002","value":"-3.94","lowerLimit":"-4.52","upperLimit":"-3.37"},{"groupId":"OG003","value":"-4.75","lowerLimit":"-5.33","upperLimit":"-4.18"}]}]},{"title":"from baseline to 54 weeks","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"98"},{"groupId":"OG002","value":"253"},{"groupId":"OG003","value":"250"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-0.94","lowerLimit":"-1.94","upperLimit":"0.07"},{"groupId":"OG001","value":"-3.20","lowerLimit":"-4.28","upperLimit":"-2.12"},{"groupId":"OG002","value":"-3.09","lowerLimit":"-3.77","upperLimit":"-2.42"},{"groupId":"OG003","value":"-4.35","lowerLimit":"-5.03","upperLimit":"-3.68"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"groupDescription":"Week 14","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-1.95","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-3.03","ciUpperLimit":"-0.87"},{"groupIds":["OG000","OG002"],"groupDescription":"Week 14","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-2.75","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-3.63","ciUpperLimit":"-1.86"},{"groupIds":["OG000","OG003"],"groupDescription":"Week 14","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-3.71","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-4.60","ciUpperLimit":"-2.82"},{"groupIds":["OG000","OG001"],"groupDescription":"Week 26","nonInferiorityType":"SUPERIORITY","pValue":"0.002","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-2.01","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-3.27","ciUpperLimit":"-0.74"},{"groupIds":["OG000","OG002"],"groupDescription":"Week 26","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-2.74","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-3.78","ciUpperLimit":"-1.71"},{"groupIds":["OG000","OG003"],"groupDescription":"Week 26","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-3.55","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-4.59","ciUpperLimit":"-2.52"},{"groupIds":["OG000","OG001"],"groupDescription":"Week 54","nonInferiorityType":"SUPERIORITY","pValue":"0.003","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-2.27","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-3.74","ciUpperLimit":"-0.79"},{"groupIds":["OG000","OG002"],"groupDescription":"Week 54","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-2.16","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-3.37","ciUpperLimit":"-0.95"},{"groupIds":["OG000","OG003"],"groupDescription":"Week 54","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-3.42","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-4.63","ciUpperLimit":"-2.20"}]},{"type":"SECONDARY","title":"Percent Change in Body Weight Versus Active Comparator","description":"To assess the effect of 100, 200, and 300 μg of cotadutide on body weight versus liraglutide 1.8 mg once daily","populationDescription":"ITT population","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"percentage","timeFrame":"from baseline to 14 weeks, 26 weeks and 54 weeks","groups":[{"id":"OG000","title":"Liraglutide","description":"Liraglutide / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG001","title":"MEDI0382 100 mcg","description":"MEDI0382 low dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG002","title":"MEDI0382 200 mcg","description":"MEDI0382 mid dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG003","title":"MEDI0382 300 mcg","description":"MEDI0382 high dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"110"},{"groupId":"OG001","value":"100"},{"groupId":"OG002","value":"256"},{"groupId":"OG003","value":"256"}]}],"classes":[{"title":"Percent change at 14 weeks","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"106"},{"groupId":"OG001","value":"94"},{"groupId":"OG002","value":"248"},{"groupId":"OG003","value":"245"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-3.40","lowerLimit":"-4.14","upperLimit":"-2.65"},{"groupId":"OG001","value":"-2.70","lowerLimit":"-3.49","upperLimit":"-1.91"},{"groupId":"OG002","value":"-3.47","lowerLimit":"-3.95","upperLimit":"-2.98"},{"groupId":"OG003","value":"-4.33","lowerLimit":"-4.82","upperLimit":"-3.84"}]}]},{"title":"Percent change at 26 weeks","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"110"},{"groupId":"OG001","value":"98"},{"groupId":"OG002","value":"253"},{"groupId":"OG003","value":"250"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-4.12","lowerLimit":"-4.98","upperLimit":"-3.27"},{"groupId":"OG001","value":"-3.23","lowerLimit":"-4.13","upperLimit":"-2.32"},{"groupId":"OG002","value":"-3.94","lowerLimit":"-4.51","upperLimit":"-3.38"},{"groupId":"OG003","value":"-4.60","lowerLimit":"-5.17","upperLimit":"-4.04"}]}]},{"title":"Percent change at 54 weeks","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"110"},{"groupId":"OG001","value":"98"},{"groupId":"OG002","value":"253"},{"groupId":"OG003","value":"250"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-3.20","lowerLimit":"-4.19","upperLimit":"-2.21"},{"groupId":"OG001","value":"-3.27","lowerLimit":"-4.32","upperLimit":"-2.22"},{"groupId":"OG002","value":"-3.08","lowerLimit":"-3.73","upperLimit":"-2.43"},{"groupId":"OG003","value":"-4.16","lowerLimit":"-4.81","upperLimit":"-3.50"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"groupDescription":"Percent change at Week 14","nonInferiorityType":"SUPERIORITY","pValue":"0.211","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"0.70","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-0.39","ciUpperLimit":"1.79"},{"groupIds":["OG000","OG002"],"groupDescription":"Percent change at Week 14","nonInferiorityType":"SUPERIORITY","pValue":"0.881","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-0.07","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-0.96","ciUpperLimit":"0.83"},{"groupIds":["OG000","OG003"],"groupDescription":"Percent change at Week 14","nonInferiorityType":"SUPERIORITY","pValue":"0.042","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-0.93","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-1.82","ciUpperLimit":"-0.04"},{"groupIds":["OG000","OG001"],"groupDescription":"Percent change at Week 26","nonInferiorityType":"SUPERIORITY","pValue":"0.158","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"0.90","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-0.35","ciUpperLimit":"2.14"},{"groupIds":["OG000","OG002"],"groupDescription":"Percent change at Week 26","nonInferiorityType":"SUPERIORITY","pValue":"0.734","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"0.18","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-0.85","ciUpperLimit":"1.20"},{"groupIds":["OG000","OG003"],"groupDescription":"Percent change at Week 26","nonInferiorityType":"SUPERIORITY","pValue":"0.357","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-0.48","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-1.51","ciUpperLimit":"0.54"},{"groupIds":["OG000","OG001"],"groupDescription":"Percent change at Week 54","nonInferiorityType":"SUPERIORITY","pValue":"0.921","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-0.07","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-1.51","ciUpperLimit":"1.37"},{"groupIds":["OG000","OG002"],"groupDescription":"Percent change at Week 54","nonInferiorityType":"SUPERIORITY","pValue":"0.847","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"0.12","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-1.07","ciUpperLimit":"1.30"},{"groupIds":["OG000","OG003"],"groupDescription":"Percent change at Week 54","nonInferiorityType":"SUPERIORITY","pValue":"0.112","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-0.96","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-2.15","ciUpperLimit":"0.22"}]},{"type":"SECONDARY","title":"Absolute Change in Body Weight Versus Active Comparator","description":"To assess the effect of 100, 200, and 300 μg of cotadutide on body weight versus liraglutide 1.8 mg once daily","populationDescription":"ITT population","reportingStatus":"POSTED","paramType":"LEAST_SQUARES_MEAN","dispersionType":"95% Confidence Interval","unitOfMeasure":"kg","timeFrame":"from baseline to 14 weeks, 26 weeks and 54 weeks","groups":[{"id":"OG000","title":"Liraglutide","description":"Liraglutide / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG001","title":"MEDI0382 100 mcg","description":"MEDI0382 low dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG002","title":"MEDI0382 200 mcg","description":"MEDI0382 mid dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG003","title":"MEDI0382 300 mcg","description":"MEDI0382 high dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"110"},{"groupId":"OG001","value":"100"},{"groupId":"OG002","value":"256"},{"groupId":"OG003","value":"256"}]}],"classes":[{"title":"Absolute change at 14 weeks","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"106"},{"groupId":"OG001","value":"94"},{"groupId":"OG002","value":"248"},{"groupId":"OG003","value":"245"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-3.25","lowerLimit":"-4.00","upperLimit":"-2.51"},{"groupId":"OG001","value":"-2.66","lowerLimit":"-3.45","upperLimit":"-1.87"},{"groupId":"OG002","value":"-3.45","lowerLimit":"-3.94","upperLimit":"-2.97"},{"groupId":"OG003","value":"-4.42","lowerLimit":"-4.91","upperLimit":"-3.93"}]}]},{"title":"Absolute change at 26 weeks","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"110"},{"groupId":"OG001","value":"98"},{"groupId":"OG002","value":"253"},{"groupId":"OG003","value":"250"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-3.90","lowerLimit":"-4.77","upperLimit":"-3.03"},{"groupId":"OG001","value":"-3.20","lowerLimit":"-4.13","upperLimit":"-2.28"},{"groupId":"OG002","value":"-3.94","lowerLimit":"-4.52","upperLimit":"-3.37"},{"groupId":"OG003","value":"-4.75","lowerLimit":"-5.33","upperLimit":"-4.18"}]}]},{"title":"Absolute change at 54 weeks","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"110"},{"groupId":"OG001","value":"98"},{"groupId":"OG002","value":"253"},{"groupId":"OG003","value":"250"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"-2.94","lowerLimit":"-3.96","upperLimit":"-1.92"},{"groupId":"OG001","value":"-3.20","lowerLimit":"-4.28","upperLimit":"-2.12"},{"groupId":"OG002","value":"-3.09","lowerLimit":"-3.77","upperLimit":"-2.42"},{"groupId":"OG003","value":"-4.35","lowerLimit":"-5.03","upperLimit":"-3.68"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"groupDescription":"Absolute change at Week 14","nonInferiorityType":"SUPERIORITY","pValue":"0.284","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"0.59","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-0.49","ciUpperLimit":"1.68"},{"groupIds":["OG000","OG002"],"groupDescription":"Absolute change at Week 14","nonInferiorityType":"SUPERIORITY","pValue":"0.658","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-0.20","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-1.09","ciUpperLimit":"0.69"},{"groupIds":["OG000","OG003"],"groupDescription":"Absolute change at Week 14","nonInferiorityType":"SUPERIORITY","pValue":"0.010","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-1.17","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-2.06","ciUpperLimit":"-0.27"},{"groupIds":["OG000","OG001"],"groupDescription":"Absolute change at Week 26","nonInferiorityType":"SUPERIORITY","pValue":"0.279","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"0.70","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-0.57","ciUpperLimit":"1.97"},{"groupIds":["OG000","OG002"],"groupDescription":"Absolute change at Week 26","nonInferiorityType":"SUPERIORITY","pValue":"0.940","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-0.04","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-1.08","ciUpperLimit":"1.00"},{"groupIds":["OG000","OG003"],"groupDescription":"Absolute change at Week 26","nonInferiorityType":"SUPERIORITY","pValue":"0.110","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-0.85","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-1.89","ciUpperLimit":"0.19"},{"groupIds":["OG000","OG001"],"groupDescription":"Absolute change at Week 54","nonInferiorityType":"SUPERIORITY","pValue":"0.730","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-0.26","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-1.74","ciUpperLimit":"1.22"},{"groupIds":["OG000","OG002"],"groupDescription":"Absolute change at Week 54","nonInferiorityType":"SUPERIORITY","pValue":"0.804","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-0.15","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-1.38","ciUpperLimit":"1.07"},{"groupIds":["OG000","OG003"],"groupDescription":"Absolute change at Week 54","nonInferiorityType":"SUPERIORITY","pValue":"0.023","statisticalMethod":"ANCOVA","paramType":"LS Mean Difference","paramValue":"-1.41","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"-2.63","ciUpperLimit":"-0.19"}]},{"type":"SECONDARY","title":"Percentage of Participants Achieving Weight Loss of ≥5% and ≥10%","description":"To assess the effect of 100, 200, and 300 μg of cotadutide on percentage of subjects achieving weight loss of ≥5% and ≥10% versus placebo","populationDescription":"ITT population","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"after 14 weeks, 26 weeks and 54 weeks","groups":[{"id":"OG000","title":"Placebo","description":"Placebo / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG001","title":"MEDI0382 100 mcg","description":"MEDI0382 low dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG002","title":"MEDI0382 200 mcg","description":"MEDI0382 mid dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG003","title":"MEDI0382 300 mcg","description":"MEDI0382 high dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"100"},{"groupId":"OG002","value":"256"},{"groupId":"OG003","value":"256"}]}],"classes":[{"title":"Participants with weight loss ≥5% at Wk 14 (LOCF)","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"108"},{"groupId":"OG001","value":"94"},{"groupId":"OG002","value":"248"},{"groupId":"OG003","value":"245"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"65"},{"groupId":"OG003","value":"92"}]}]},{"title":"Participants with weight loss ≥5% at Wk 26 (LOCF)","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"98"},{"groupId":"OG002","value":"253"},{"groupId":"OG003","value":"250"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"76"},{"groupId":"OG003","value":"110"}]}]},{"title":"Participants with weight loss ≥5% at Wk 54 (LOCF)","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"98"},{"groupId":"OG002","value":"253"},{"groupId":"OG003","value":"250"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"14"},{"groupId":"OG001","value":"34"},{"groupId":"OG002","value":"71"},{"groupId":"OG003","value":"98"}]}]},{"title":"Participants with weight loss ≥10% at Wk 14 (LOCF)","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"108"},{"groupId":"OG001","value":"94"},{"groupId":"OG002","value":"248"},{"groupId":"OG003","value":"245"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"15"},{"groupId":"OG003","value":"20"}]}]},{"title":"Participants with weight loss ≥10% at Wk 26 (LOCF)","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"98"},{"groupId":"OG002","value":"253"},{"groupId":"OG003","value":"250"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"28"},{"groupId":"OG003","value":"27"}]}]},{"title":"Participants with weight loss ≥10% at Wk 54 (LOCF)","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"98"},{"groupId":"OG002","value":"253"},{"groupId":"OG003","value":"250"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"11"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"32"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"groupDescription":"weight loss \\>=5% at Week 14","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"8.37","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"2.38","ciUpperLimit":"29.43"},{"groupIds":["OG000","OG002"],"groupDescription":"weight loss \\>=5% at Week 14","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"12.46","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"3.82","ciUpperLimit":"40.64"},{"groupIds":["OG000","OG003"],"groupDescription":"weight loss \\>=5% at Week 14","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"21.26","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"6.55","ciUpperLimit":"68.97"},{"groupIds":["OG000","OG001"],"groupDescription":"weight loss \\>=5% at Week 26","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"3.68","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"1.72","ciUpperLimit":"7.89"},{"groupIds":["OG000","OG002"],"groupDescription":"weight loss \\>=5% at Week 26","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"3.95","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"2.00","ciUpperLimit":"7.78"},{"groupIds":["OG000","OG003"],"groupDescription":"weight loss \\>=5% at Week 26","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"7.28","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"3.72","ciUpperLimit":"14.24"},{"groupIds":["OG000","OG001"],"groupDescription":"weight loss \\>=5% at Week 54","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"3.71","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"1.84","ciUpperLimit":"7.45"},{"groupIds":["OG000","OG002"],"groupDescription":"weight loss \\>=5% at Week 54","nonInferiorityType":"SUPERIORITY","pValue":"0.002","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"2.73","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"1.46","ciUpperLimit":"5.09"},{"groupIds":["OG000","OG003"],"groupDescription":"weight loss \\>=5% at Week 54","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"ANCOVA","paramType":"Odds Ratio, log","paramValue":"4.48","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"2.42","ciUpperLimit":"8.30"},{"groupIds":["OG000","OG001"],"groupDescription":"weight loss \\>=10% at Week 26","nonInferiorityType":"SUPERIORITY","pValue":"0.048","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"8.47","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"1.02","ciUpperLimit":"70.17"},{"groupIds":["OG000","OG002"],"groupDescription":"weight loss \\>=10% at Week 26","nonInferiorityType":"SUPERIORITY","pValue":"0.010","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"13.81","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"1.85","ciUpperLimit":"102.91"},{"groupIds":["OG000","OG003"],"groupDescription":"weight loss \\>=10% at Week 26","nonInferiorityType":"SUPERIORITY","pValue":"0.012","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"13.09","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"1.75","ciUpperLimit":"97.68"},{"groupIds":["OG000","OG001"],"groupDescription":"weight loss \\>=10% at Week 54","nonInferiorityType":"SUPERIORITY","pValue":"0.013","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"6.92","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"1.49","ciUpperLimit":"32.07"},{"groupIds":["OG000","OG002"],"groupDescription":"weight loss \\>=10% at Week 54","nonInferiorityType":"SUPERIORITY","pValue":"0.032","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"4.98","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"1.15","ciUpperLimit":"21.60"},{"groupIds":["OG000","OG003"],"groupDescription":"weight loss \\>=10% at Week 54","nonInferiorityType":"SUPERIORITY","pValue":"0.005","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"7.91","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"1.86","ciUpperLimit":"33.64"}]},{"type":"SECONDARY","title":"Percentage of Participants Rescued or Discontinued for Lack of Glycaemic Control","description":"To assess the effect of 100, 200, and 300 μg of cotadutide on the requirement for additional blood glucose-lowering therapies versus placebo","populationDescription":"ITT population","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"at 14 weeks, 26 weeks and 54 weeks","groups":[{"id":"OG000","title":"Placebo","description":"Placebo / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG001","title":"MEDI0382 100 mcg","description":"MEDI0382 low dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG002","title":"MEDI0382 200 mcg","description":"MEDI0382 mid dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG003","title":"MEDI0382 300 mcg","description":"MEDI0382 high dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"100"},{"groupId":"OG002","value":"256"},{"groupId":"OG003","value":"256"}]}],"classes":[{"title":"received rescue medication at 14 wks","categories":[{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"2"}]}]},{"title":"received rescue medication at 26 wks","categories":[{"measurements":[{"groupId":"OG000","value":"20"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"8"},{"groupId":"OG003","value":"6"}]}]},{"title":"received rescue medication at 54 wks","categories":[{"measurements":[{"groupId":"OG000","value":"34"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"24"}]}]},{"title":"discontinued study IP at 14 wks","categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"}]}]},{"title":"discontinued study IP at 26 wks","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"0"}]}]},{"title":"discontinued study IP at 54 wks","categories":[{"measurements":[{"groupId":"OG000","value":"4"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"0"}]}]}],"analyses":[{"groupIds":["OG000","OG001"],"groupDescription":"received rescue medication at 14 wks","nonInferiorityType":"SUPERIORITY","pValue":"0.024","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"0.09","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.01","ciUpperLimit":"0.73"},{"groupIds":["OG000","OG002"],"groupDescription":"received rescue medication at 14 wks","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"0.11","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.03","ciUpperLimit":"0.40"},{"groupIds":["OG000","OG003"],"groupDescription":"received rescue medication at 14 wks","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"0.07","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.02","ciUpperLimit":"0.33"},{"groupIds":["OG000","OG001"],"groupDescription":"received rescue medication at 26 wks","nonInferiorityType":"SUPERIORITY","pValue":"0.002","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"0.14","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.04","ciUpperLimit":"0.48"},{"groupIds":["OG000","OG002"],"groupDescription":"received rescue medication at 26 wks","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"0.14","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.06","ciUpperLimit":"0.34"},{"groupIds":["OG000","OG003"],"groupDescription":"received rescue medication at 26 wks","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"0.11","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.04","ciUpperLimit":"0.28"},{"groupIds":["OG000","OG001"],"groupDescription":"received rescue medication at 54 wks","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"0.24","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.11","ciUpperLimit":"0.53"},{"groupIds":["OG000","OG002"],"groupDescription":"received rescue medication at 54 wks","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"0.24","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.13","ciUpperLimit":"0.44"},{"groupIds":["OG000","OG003"],"groupDescription":"received rescue medication at 54 wks","nonInferiorityType":"SUPERIORITY","pValue":"<0.001","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"0.22","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.12","ciUpperLimit":"0.41"},{"groupIds":["OG000","OG002"],"groupDescription":"discontinued IP at 14 wks","nonInferiorityType":"SUPERIORITY","pValue":"0.216","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"0.22","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.02","ciUpperLimit":"2.43"},{"groupIds":["OG000","OG001"],"groupDescription":"discontinued IP at 26 wks","nonInferiorityType":"SUPERIORITY","pValue":"0.253","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"0.28","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.03","ciUpperLimit":"2.52"},{"groupIds":["OG000","OG002"],"groupDescription":"discontinued IP at 26 wks","nonInferiorityType":"SUPERIORITY","pValue":"0.079","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"0.21","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.04","ciUpperLimit":"1.19"},{"groupIds":["OG000","OG001"],"groupDescription":"discontinued IP at 54 wks","nonInferiorityType":"SUPERIORITY","pValue":"0.252","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"0.27","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.03","ciUpperLimit":"2.50"},{"groupIds":["OG000","OG002"],"groupDescription":"discontinued IP at 54 wks","nonInferiorityType":"SUPERIORITY","pValue":"0.143","statisticalMethod":"Regression, Logistic","paramType":"Odds Ratio, log","paramValue":"0.32","ciPctValue":"95","ciNumSides":"TWO_SIDED","ciLowerLimit":"0.07","ciUpperLimit":"1.47"}]},{"type":"SECONDARY","title":"Pharmacokinetic (PK) Endpoint: Trough Plasma Concentration (Cmin)","description":"To characterise the PK profile of 100, 200, and 300 μg of cotadutide","populationDescription":"Per-protocol population","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"ng/mL","timeFrame":"Time points at which outcome measure were assessed for plasma concentration were Weeks 1,2,6,10,14,18,22,26, and 54","groups":[{"id":"OG000","title":"Placebo","description":"Placebo / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG001","title":"MEDI0382 100 mcg","description":"MEDI0382 low dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG002","title":"MEDI0382 200 mcg","description":"MEDI0382 mid dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG003","title":"MEDI0382 300 mcg","description":"MEDI0382 high dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"100"},{"groupId":"OG002","value":"256"},{"groupId":"OG003","value":"256"}]}],"classes":[{"title":"Week 1","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"67"},{"groupId":"OG002","value":"179"},{"groupId":"OG003","value":"170"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"2.68","spread":"1.27"},{"groupId":"OG002","value":"2.76","spread":"1.88"},{"groupId":"OG003","value":"2.77","spread":"1.84"}]}]},{"title":"Week 2","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"69"},{"groupId":"OG002","value":"180"},{"groupId":"OG003","value":"168"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"2.66","spread":"1.61"},{"groupId":"OG002","value":"5.13","spread":"3.23"},{"groupId":"OG003","value":"5.18","spread":"3.05"}]}]},{"title":"Week 6","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"69"},{"groupId":"OG002","value":"192"},{"groupId":"OG003","value":"177"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"2.75","spread":"1.44"},{"groupId":"OG002","value":"5.20","spread":"3.57"},{"groupId":"OG003","value":"7.77","spread":"4.88"}]}]},{"title":"Week 10","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"71"},{"groupId":"OG002","value":"181"},{"groupId":"OG003","value":"172"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"3.18","spread":"2.26"},{"groupId":"OG002","value":"5.74","spread":"4.23"},{"groupId":"OG003","value":"8.23","spread":"4.31"}]}]},{"title":"Week 14","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"72"},{"groupId":"OG002","value":"184"},{"groupId":"OG003","value":"178"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"3.79","spread":"4.05"},{"groupId":"OG002","value":"6.50","spread":"5.26"},{"groupId":"OG003","value":"9.71","spread":"7.64"}]}]},{"title":"Week 18","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"69"},{"groupId":"OG002","value":"180"},{"groupId":"OG003","value":"169"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"4.58","spread":"5.04"},{"groupId":"OG002","value":"7.43","spread":"6.43"},{"groupId":"OG003","value":"10.8","spread":"7.95"}]}]},{"title":"Week 22","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"70"},{"groupId":"OG002","value":"177"},{"groupId":"OG003","value":"168"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"4.63","spread":"4.28"},{"groupId":"OG002","value":"8.07","spread":"7.01"},{"groupId":"OG003","value":"11.5","spread":"9.77"}]}]},{"title":"Week 26","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"69"},{"groupId":"OG002","value":"183"},{"groupId":"OG003","value":"167"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"4.39","spread":"3.33"},{"groupId":"OG002","value":"8.12","spread":"7.31"},{"groupId":"OG003","value":"12.9","spread":"12.1"}]}]},{"title":"Week 54","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"69"},{"groupId":"OG002","value":"180"},{"groupId":"OG003","value":"166"}]}],"categories":[{"measurements":[{"groupId":"OG001","value":"4.58","spread":"3.89"},{"groupId":"OG002","value":"8.99","spread":"9.22"},{"groupId":"OG003","value":"13.2","spread":"14.3"}]}]}]},{"type":"SECONDARY","title":"Immunogenicity Endpoint: Overall Antidrug Antibody (ADA) Incidence (Number and Percentage of Positive Partipants)","description":"To characterise the immunogenicity of 100, 200, and 300 μg of cotadutide","populationDescription":"As-treated population","reportingStatus":"POSTED","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","timeFrame":"Baseline through 54-week treatment period and 28-day follow-up","groups":[{"id":"OG000","title":"Placebo","description":"Placebo / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG001","title":"MEDI0382 100 mcg","description":"MEDI0382 low dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG002","title":"MEDI0382 200 mcg","description":"MEDI0382 mid dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG003","title":"MEDI0382 300 mcg","description":"MEDI0382 high dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"100"},{"groupId":"OG002","value":"256"},{"groupId":"OG003","value":"256"}]}],"classes":[{"title":"ADA positive at baseline","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"111"},{"groupId":"OG001","value":"98"},{"groupId":"OG002","value":"250"},{"groupId":"OG003","value":"249"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"}]}]},{"title":"ADA incidence","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"111"},{"groupId":"OG001","value":"97"},{"groupId":"OG002","value":"248"},{"groupId":"OG003","value":"250"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"55"},{"groupId":"OG002","value":"152"},{"groupId":"OG003","value":"155"}]}]},{"title":"ADA positive post-baseline","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"111"},{"groupId":"OG001","value":"97"},{"groupId":"OG002","value":"248"},{"groupId":"OG003","value":"250"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"54"},{"groupId":"OG002","value":"152"},{"groupId":"OG003","value":"155"}]}]}]},{"type":"SECONDARY","title":"Immunogenicity Endpoint: Median Titer of the Anti-Drug Antibodies (ADA) to MEDI0382 in the Positive Participants","description":"To characterise the immunogenicity of 100, 200, and 300 μg of cotadutide","populationDescription":"As-treated population","reportingStatus":"POSTED","paramType":"MEDIAN","dispersionType":"Full Range","unitOfMeasure":"titer","timeFrame":"Baseline through 54-week treatment period and 28-day follow-up","groups":[{"id":"OG000","title":"Placebo","description":"Placebo / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG001","title":"MEDI0382 100 mcg","description":"MEDI0382 low dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG002","title":"MEDI0382 200 mcg","description":"MEDI0382 mid dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"},{"id":"OG003","title":"MEDI0382 300 mcg","description":"MEDI0382 high dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"112"},{"groupId":"OG001","value":"100"},{"groupId":"OG002","value":"256"},{"groupId":"OG003","value":"256"}]}],"classes":[{"title":"ADA positive at baseline, median titer","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"111"},{"groupId":"OG001","value":"98"},{"groupId":"OG002","value":"250"},{"groupId":"OG003","value":"249"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5.0","lowerLimit":"5","upperLimit":"5"},{"groupId":"OG001","value":"5.0","lowerLimit":"5","upperLimit":"5"},{"groupId":"OG002","value":"0","lowerLimit":"0","upperLimit":"0"},{"groupId":"OG003","value":"0","lowerLimit":"0","upperLimit":"0"}]}]},{"title":"ADA incidence, median of maximum titer","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"111"},{"groupId":"OG001","value":"97"},{"groupId":"OG002","value":"248"},{"groupId":"OG003","value":"250"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5.0","lowerLimit":"5","upperLimit":"20"},{"groupId":"OG001","value":"20.0","lowerLimit":"5","upperLimit":"2560"},{"groupId":"OG002","value":"20.0","lowerLimit":"5","upperLimit":"640"},{"groupId":"OG003","value":"20.0","lowerLimit":"5","upperLimit":"5120"}]}]},{"title":"ADA positive post-baseline, median of max. titer","denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"111"},{"groupId":"OG001","value":"97"},{"groupId":"OG002","value":"248"},{"groupId":"OG003","value":"250"}]}],"categories":[{"measurements":[{"groupId":"OG000","value":"5.0","lowerLimit":"5","upperLimit":"20"},{"groupId":"OG001","value":"20.0","lowerLimit":"5","upperLimit":"2560"},{"groupId":"OG002","value":"20.0","lowerLimit":"5","upperLimit":"640"},{"groupId":"OG003","value":"20.0","lowerLimit":"5","upperLimit":"5120"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"5","timeFrame":"Adverse events were collected from time of first IP dose throughout the 54-week treatment period and including the 28-day follow-up period. Serious AEs were recorded from the time of signature of informed consent.","eventGroups":[{"id":"EG000","title":"Placebo","description":"Placebo / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)","deathsNumAffected":0,"deathsNumAtRisk":112,"seriousNumAffected":12,"seriousNumAtRisk":112,"otherNumAffected":45,"otherNumAtRisk":112},{"id":"EG001","title":"Liraglutide","description":"Liraglutide + Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)","deathsNumAffected":0,"deathsNumAtRisk":110,"seriousNumAffected":8,"seriousNumAtRisk":110,"otherNumAffected":36,"otherNumAtRisk":110},{"id":"EG002","title":"MEDI0382 100 mcg","description":"MEDI0382 low dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)","deathsNumAffected":0,"deathsNumAtRisk":100,"seriousNumAffected":12,"seriousNumAtRisk":100,"otherNumAffected":51,"otherNumAtRisk":100},{"id":"EG003","title":"MEDI0382 200 mcg","description":"MEDI0382 mid dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)","deathsNumAffected":2,"deathsNumAtRisk":256,"seriousNumAffected":33,"seriousNumAtRisk":256,"otherNumAffected":159,"otherNumAtRisk":256},{"id":"EG004","title":"MEDI0382 300 mcg","description":"MEDI0382 high dose / Metformin tablets, total daily dose of ≥1500 mg (unless only tolerated at a lower dose)","deathsNumAffected":1,"deathsNumAtRisk":256,"seriousNumAffected":20,"seriousNumAtRisk":256,"otherNumAffected":164,"otherNumAtRisk":256}],"seriousEvents":[{"term":"Acute myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Angina pectoris","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Angina unstable","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":100},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Aortic valve stenosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Arteriosclerosis coronary artery","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Atrial fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":2,"numAffected":1,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Atrial flutter","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Atrioventricular block complete","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Bradycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Cardiac failure chronic","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Cardiac failure congestive","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Coronary artery disease","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Myocardial ischaemia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Silent myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Retinal detachment","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Retinal tear","organSystem":"Eye disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Abdominal pain upper","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Colitis ulcerative","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Enterocutaneous fistula","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Gastric polyps","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Gastrooesophageal reflux disease","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Hiatus hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Inguinal hernia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Irritable bowel syndrome","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Megacolon","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Pancreatitis acute","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Retroperitoneal haematoma","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Impaired healing","organSystem":"General disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Cholecystitis acute","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Cholelithiasis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":100},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Gallbladder polyp","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Hepatic cirrhosis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Acarodermatitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Appendicitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Bacterial infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Chronic sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Erysipelas","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Gastroenteritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Otitis media acute","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":110},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Postoperative wound infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Pyelonephritis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Pyelonephritis chronic","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Skin infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Anastomotic leak","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Arterial bypass occlusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Concussion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Craniocerebral injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Humerus fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":2,"numAffected":1,"numAtRisk":256}]},{"term":"Limb injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Post procedural fistula","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Spinal column injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Subcutaneous haematoma","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Tibia fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Upper limb fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Diabetic metabolic decompensation","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Arthrofibrosis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Haematoma muscle","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Intervertebral disc protrusion","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Meniscal degeneration","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":2,"numAffected":1,"numAtRisk":256}]},{"term":"Osteoarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":100},{"groupId":"EG003","numEvents":3,"numAffected":3,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Rotator cuff syndrome","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Acute leukaemia","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Gastrointestinal stromal tumour","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Lymphoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Pancreatic carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Prostate cancer metastatic","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Tongue neoplasm malignant stage unspecified","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Triple negative breast cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Cerebrovascular disorder","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Diabetic neuropathy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Haemorrhagic stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Ischaemic stroke","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Transient ischaemic attack","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Vertigo cns origin","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Chronic kidney disease","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Nephrolithiasis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Perinephritis","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Prerenal failure","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Urinary tract disorder","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Acquired phimosis","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Uterine prolapse","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Acute respiratory failure","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Asthma","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Dysphonia","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Pulmonary oedema","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Vocal cord dysfunction","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":256},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":256}]},{"term":"Hypertensive crisis","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":100},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]},{"term":"Peripheral arterial occlusive disease","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":100},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":256},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":256}]}],"otherEvents":[{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":112},{"groupId":"EG001","numEvents":3,"numAffected":2,"numAtRisk":110},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":100},{"groupId":"EG003","numEvents":10,"numAffected":10,"numAtRisk":256},{"groupId":"EG004","numEvents":14,"numAffected":13,"numAtRisk":256}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":10,"numAffected":10,"numAtRisk":112},{"groupId":"EG001","numEvents":7,"numAffected":4,"numAtRisk":110},{"groupId":"EG002","numEvents":15,"numAffected":13,"numAtRisk":100},{"groupId":"EG003","numEvents":68,"numAffected":49,"numAtRisk":256},{"groupId":"EG004","numEvents":40,"numAffected":28,"numAtRisk":256}]},{"term":"Dyspepsia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":112},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":110},{"groupId":"EG002","numEvents":13,"numAffected":7,"numAtRisk":100},{"groupId":"EG003","numEvents":26,"numAffected":19,"numAtRisk":256},{"groupId":"EG004","numEvents":38,"numAffected":28,"numAtRisk":256}]},{"term":"Eructation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":100},{"groupId":"EG003","numEvents":17,"numAffected":14,"numAtRisk":256},{"groupId":"EG004","numEvents":15,"numAffected":12,"numAtRisk":256}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":13,"numAffected":12,"numAtRisk":112},{"groupId":"EG001","numEvents":21,"numAffected":17,"numAtRisk":110},{"groupId":"EG002","numEvents":28,"numAffected":23,"numAtRisk":100},{"groupId":"EG003","numEvents":115,"numAffected":85,"numAtRisk":256},{"groupId":"EG004","numEvents":143,"numAffected":105,"numAtRisk":256}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":5,"numAtRisk":112},{"groupId":"EG001","numEvents":3,"numAffected":3,"numAtRisk":110},{"groupId":"EG002","numEvents":12,"numAffected":10,"numAtRisk":100},{"groupId":"EG003","numEvents":66,"numAffected":51,"numAtRisk":256},{"groupId":"EG004","numEvents":58,"numAffected":43,"numAtRisk":256}]},{"term":"Nasopharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":19,"numAffected":15,"numAtRisk":112},{"groupId":"EG001","numEvents":13,"numAffected":11,"numAtRisk":110},{"groupId":"EG002","numEvents":13,"numAffected":11,"numAtRisk":100},{"groupId":"EG003","numEvents":28,"numAffected":22,"numAtRisk":256},{"groupId":"EG004","numEvents":44,"numAffected":28,"numAtRisk":256}]},{"term":"Respiratory tract infection viral","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":112},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":110},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":100},{"groupId":"EG003","numEvents":15,"numAffected":13,"numAtRisk":256},{"groupId":"EG004","numEvents":8,"numAffected":7,"numAtRisk":256}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":112},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":110},{"groupId":"EG002","numEvents":4,"numAffected":3,"numAtRisk":100},{"groupId":"EG003","numEvents":17,"numAffected":13,"numAtRisk":256},{"groupId":"EG004","numEvents":9,"numAffected":7,"numAtRisk":256}]},{"term":"Decreased appetite","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":110},{"groupId":"EG002","numEvents":3,"numAffected":3,"numAtRisk":100},{"groupId":"EG003","numEvents":12,"numAffected":12,"numAtRisk":256},{"groupId":"EG004","numEvents":14,"numAffected":14,"numAtRisk":256}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":6,"numAffected":6,"numAtRisk":112},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":110},{"groupId":"EG002","numEvents":8,"numAffected":8,"numAtRisk":100},{"groupId":"EG003","numEvents":12,"numAffected":9,"numAtRisk":256},{"groupId":"EG004","numEvents":9,"numAffected":9,"numAtRisk":256}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":3,"numAffected":3,"numAtRisk":112},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":110},{"groupId":"EG002","numEvents":5,"numAffected":4,"numAtRisk":100},{"groupId":"EG003","numEvents":12,"numAffected":11,"numAtRisk":256},{"groupId":"EG004","numEvents":19,"numAffected":15,"numAtRisk":256}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA 22","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":112},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":110},{"groupId":"EG002","numEvents":4,"numAffected":3,"numAtRisk":100},{"groupId":"EG003","numEvents":18,"numAffected":15,"numAtRisk":256},{"groupId":"EG004","numEvents":23,"numAffected":19,"numAtRisk":256}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"The Principal Investigator shall provide AstraZeneca with copies of any materials relating to the Study, the Study Documentation, or the Developed Technologies that either Party intends to publish (or submit for publication) or make any presentations relating to, at least 60 days in advance of publication, submission or presentation."},"pointOfContact":{"title":"AstraZenenca Information Center","organization":"AstraZeneca","email":"information.center@astrazeneca.com","phone":"1-877-240-9479"}}},"documentSection":{"largeDocumentModule":{"largeDocs":[{"typeAbbrev":"Prot","hasProtocol":true,"hasSap":false,"hasIcf":false,"label":"Study Protocol","date":"2018-12-04","uploadDate":"2020-07-31T11:11","filename":"Prot_002.pdf","size":4109683},{"typeAbbrev":"SAP","hasProtocol":false,"hasSap":true,"hasIcf":false,"label":"Statistical Analysis Plan","date":"2019-03-20","uploadDate":"2020-07-31T11:11","filename":"SAP_003.pdf","size":624659}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-10-09","removedCountries":["Hungary"],"submissionTracking":{"firstMcpInfo":{"postDateStruct":{"date":"2020-06-22","type":"ACTUAL"}}}},"conditionBrowseModule":{"meshes":[{"id":"D003924","term":"Diabetes Mellitus, Type 2"}],"ancestors":[{"id":"D003920","term":"Diabetes Mellitus"},{"id":"D044882","term":"Glucose Metabolism Disorders"},{"id":"D008659","term":"Metabolic Diseases"},{"id":"D009750","term":"Nutritional and Metabolic Diseases"},{"id":"D004700","term":"Endocrine System Diseases"}]},"interventionBrowseModule":{"meshes":[{"id":"C000624433","term":"cotadutide"},{"id":"D000069450","term":"Liraglutide"}],"ancestors":[{"id":"D052216","term":"Glucagon-Like Peptide 1"},{"id":"D004763","term":"Glucagon-Like Peptides"},{"id":"D052336","term":"Proglucagon"},{"id":"D005768","term":"Gastrointestinal Hormones"},{"id":"D006728","term":"Hormones"},{"id":"D006730","term":"Hormones, Hormone Substitutes, and Hormone Antagonists"}]}},"hasResults":true}